التفاصيل البيبلوغرافية
| العنوان: |
Imaging post-177Lu-peptide receptor radionuclide therapy in a child with advanced progressive somatostatin-receptor-positive medulloblastoma. |
| المؤلفون: |
Pizzoferro, Milena1 (AUTHOR) milena.pizzoferro@opbg.net, Cassano, Bartolomeo2 (AUTHOR), Altini, Claudio1 (AUTHOR), Cacchione, Antonella3 (AUTHOR), Cefalo, Maria Giuseppina3 (AUTHOR), Cannatà, Vittorio2 (AUTHOR), Garganese, Maria Carmen1 (AUTHOR) |
| المصدر: |
European Journal of Nuclear Medicine & Molecular Imaging. Mar2021, Vol. 48 Issue 3, p937-939. 3p. 1 Graph. |
| مصطلحات موضوعية: |
*MEDULLOBLASTOMA, *RADIOISOTOPES, *SOMATOSTATIN receptors, *RADIONUCLIDE imaging, *TUMORS in children, *ABSORBED dose |
| مستخلص: |
Medulloblastoma can overexpress somatostatin-receptor (SSTR) in different patterns and molecular imaging techniques can provide a functional assessment of tumor biology [[1]-[3]]. 177Lu-Peptide-Receptor Radionuclide Therapy (177Lu-PRRT) shows a promising role in SSTR-positive tumors with a potential utility in clinical treatment of medulloblastoma [[3]]. This article is part of the Topical Collection on Image of the month Medulloblastoma is the most common malignant intracranial tumor in children, with a poor prognosis despite aggressive treatment protocols when relapsed. [Extracted from the article] |
| قاعدة البيانات: |
Academic Search Index |
